Lung cancer is the leading cause of cancer death among both men and women in the United States, and Maine’s lung cancer rate is 30% higher than the national average. Seventy five percent of lung cancer cases in Maine are detected too late for effective treatment to be administered. Some of the factors that have contributed to this high number are absence of lung cancer screenings, late detection, limited access to a largely rural population, and lack of education materials and programs.1
The Maine Lung Cancer Coalition (MLCC) has partnered with Qualidigm to develop a statewide education program for clinicians and healthcare professionals on lung cancer screening and prevention. The program includes the development of webinars and online learning modules. Qualidigm also developed and led the MLCC Patient and Family Advisory Group, which provides input and feedback on the MLCC project.
With the help of Qualidigm, the MLCC was able to promote a greater understanding of lung cancer screening in Maine. Qualidigm will continue to provide lung cancer screening education as well as the Patient and Family Advisory Group for Years 3 and 4 in this grant, continuing the programs aimed at educating health professionals, patients and community members about lung cancer risk, prevention and screening. To further promote this education platform, Qualidigm and the MLCC will be launching a Project ECHO initiative focused on connecting smaller, community hospitals who want to start new or sustain current lung cancer screening programs with larger, established lung cancer screening programs for mentorship and the sharing of best practices.